(Q34611306)

3 August 2017

title

Focus on aripiprazole: a review of its use in child and adolescent psychiatry (English)

1 reference

child and adolescent psychiatry

3 August 2017

0 references

1 reference

1 reference

Masa'il Greenaway

1

1 reference

3 August 2017

Dean Elbe

series ordinal

2

1 reference

3 August 2017

publication date

1 August 2009

1 reference

Journal of the Canadian Academy of Child and Adolescent Psychiatry

3 August 2017

published in

1 reference

3 August 2017

volume

18

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

250-260

1 reference

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Treatment of alternating hemiplegia of childhood with aripiprazole

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole in children and adolescents: clinical experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole for maladaptive behavior in pervasive developmental disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Consensus development conference on antipsychotic drugs and obesity and diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Psychotropic drugs and the ECG: focus on the QTc interval

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Prolonged toxicity in a 2-year-old after accidental ingestion of aripiprazole

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Psychosis or atypical neuroleptic malignant syndrome in an adolescent?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Successful treatment of catatonia with aripiprazole in an adolescent with psychosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Priapism associated with oxcarbazepine, aripiprazole, and lithium

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Treatment of withdrawal dyskinesia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Reversal of symptomatic hyperprolactinemia by aripiprazole

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Case series on the use of aripiprazole for Tourette syndrome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole in the treatment of bipolar disorder in children and adolescents

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Aripiprazole and psychotherapy for delusional disorder, erotomanic type

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732733

Acute dystonia with low-dosage aripiprazole in Tourette's disorder

26 October 2018

1 reference

12 December 2020

Hyperglycemia in a 7-year-old child treated with aripiprazole

1 reference

12 December 2020

[Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients]

1 reference

12 December 2020

Acute dystonia associated with aripiprazole in a child

1 reference

12 December 2020

The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine

1 reference

12 December 2020

Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder

1 reference

12 December 2020

A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole

1 reference

12 December 2020

A pilot study of aripiprazole in children and adolescents with Tourette's disorder

1 reference

12 December 2020

Aripiprazole in childhood and adolescence for Tourette syndrome

1 reference

12 December 2020

Aripiprazole in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Neuroleptic malignant syndrome and aripiprazole

1 reference

12 December 2020

Identifiers

PMC publication ID

2732733

1 reference

3 August 2017

1 reference